Clinical Trial Update: Cefepime-taniborbactam vs Meropenem in Adults With VABP or Ventilated HABP [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating cefepime-taniborbactam versus meropenem in adults with ventilator-associated pneumonia or hospital-acquired pneumonia has been withdr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hospital-acquired Pneumonia
• Ventilator-associated Pneumonia

Drugs mentioned

• Cefepime-taniborbactam (cefepime-taniborbactam)
• Meropenem (Meropenem)

Snippet

Sponsor: Venatorx Pharmaceuticals, Inc. | Conditions: Ventilator-associated Pneumonia, Hospital-acquired Pneumonia | Phase 3 | Status: WITHDRAWN